{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T21:39:20Z","timestamp":1789421960853,"version":"build-2803163510"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":25,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-04592-6","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T02:01:08Z","timestamp":1768528868000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Targeted therapies and their outcomes in monogenic very early onset inflammatory bowel disease: a systematic review"],"prefix":"10.1186","volume":"26","author":[{"given":"Amir Parsa","family":"Abhari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parastesh","family":"Rezvanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elika","family":"Sohrabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaveh","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Attauabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashee","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimia","family":"Najafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"issue":"6","key":"4592_CR1","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1093\/ibd\/izz259","volume":"26","author":"J Ouahed","year":"2020","unstructured":"Ouahed J, Spencer E, Kotlarz D, Shouval DS, Kowalik M, Peng K, et al. Very early onset inflammatory bowel disease: a clinical approach with a focus on the role of genetics and underlying immune deficiencies. Inflamm Bowel Dis. 2020;26(6):820\u201342.","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"4592_CR2","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jpeds.2004.08.043","volume":"146","author":"MB Heyman","year":"2005","unstructured":"Heyman MB, Kirschner BS, Gold BD, Ferry G, Baldassano R, Cohen SA, et al. Children with early-onset inflammatory bowel disease (IBD): analysis of a pediatric IBD consortium registry. J Pediatr. 2005;146(1):35\u201340.","journal-title":"J Pediatr"},{"issue":"10","key":"4592_CR3","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1097\/MEG.0000000000001859","volume":"32","author":"A Srivastava","year":"2020","unstructured":"Srivastava A, Sathiyasekharan M, Jagadisan B, Bolia R, Peethambaran M, Mammayil G, et al. Paediatric inflammatory bowel disease in india: a prospective multicentre study. Eur J Gastroenterol Hepatol. 2020;32(10):1305\u201311.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"5","key":"4592_CR4","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1053\/j.gastro.2014.07.023","volume":"147","author":"HH Uhlig","year":"2014","unstructured":"Uhlig HH, Schwerd T, Koletzko S, Shah N, Kammermeier J, Elkadri A, et al. The diagnostic approach to Monogenic very early onset inflammatory bowel disease. Gastroenterology. 2014;147(5):990\u20131007. e3.","journal-title":"Gastroenterology"},{"issue":"3","key":"4592_CR5","doi-asserted-by":"publisher","first-page":"969","DOI":"10.3390\/pharmaceutics15030969","volume":"15","author":"AE Levine","year":"2023","unstructured":"Levine AE, Mark D, Smith L, Zheng HB, Suskind DL. Pharmacologic management of Monogenic and very early onset inflammatory bowel diseases. Pharmaceutics. 2023;15(3):969.","journal-title":"Pharmaceutics"},{"issue":"3","key":"4592_CR6","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.jpeds.2015.04.045","volume":"167","author":"M Oliva-Hemker","year":"2015","unstructured":"Oliva-Hemker M, Hutfless S, Al Kazzi ES, Lerer T, Mack D, LeLeiko N, et al. Clinical presentation and five-year therapeutic management of very early-onset inflammatory bowel disease in a large North American cohort. J Pediatr. 2015;167(3):527\u201332. e3.","journal-title":"J Pediatr"},{"key":"4592_CR7","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"key":"4592_CR8","doi-asserted-by":"crossref","unstructured":"Moola S, Tufanaru C, Aromataris E, Sears K, Sfetc R, Currie M et al. Chapter 7: Systematic Reviews of Etiology and Risk. 2020.","DOI":"10.46658\/JBIRM-17-06"},{"key":"4592_CR9","doi-asserted-by":"crossref","unstructured":"Wang P, Qian X, Jiang W, Wang H, Wang Y, Zhou Y, Zhang Y, Huang Y, Zhai X. Cord blood transplantation for very early-onset inflammatory bowel disease caused by interleukin-10receptor deficiency. J Clin Immunol. 2024;44(3):67.","DOI":"10.1007\/s10875-024-01669-x"},{"issue":"11","key":"4592_CR10","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1111\/apt.16837","volume":"55","author":"Z Ye","year":"2022","unstructured":"Ye Z, Qian L, Hu W, Miao S, Wang Y, Lu J, et al. Clinical outcome of infantile-onset inflammatory bowel disease in 102 patients with interleukin-10 signalling deficiency. Aliment Pharmacol Ther. 2022;55(11):1414\u201322.","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"4592_CR11","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1093\/ibd\/izy289","volume":"25","author":"C Zheng","year":"2019","unstructured":"Zheng C, Huang Y, Hu W, Shi J, Ye Z, Qian X, et al. Phenotypic characterization of very Early-Onset inflammatory bowel disease with Interleukin-10 signaling deficiency: based on a large cohort study. Inflamm Bowel Dis. 2019;25(4):756\u201366.","journal-title":"Inflamm Bowel Dis"},{"key":"4592_CR12","doi-asserted-by":"crossref","unstructured":"Baccarella A, Patel T, Conrad MA, MacchiM, Boyer B, Pickering O, MPh YB, Gaddipati S, Cohen M, Cubero A, Dawany N. Outcomes of allogeneic hematopoietic stem cell transplant in monogenic inflammatory bowel disease. Clin Gastroenterol Hepatol. 2025.","DOI":"10.1016\/j.cgh.2025.03.018"},{"issue":"2","key":"4592_CR13","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s12288-022-01586-2","volume":"39","author":"S Meena","year":"2023","unstructured":"Meena S, Varla H, Swaminathan VV, Chandar R, Jayakumar I, Ramakrishnan B, et al. Hematopoietic stem cell transplantation in children with very early onset inflammatory bowel disease secondary to Monogenic disorders of immune-dysregulation. Indian J Hematol Blood Transfus. 2023;39(2):183\u201390.","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"23","key":"4592_CR14","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1097\/CM9.0000000000000528","volume":"132","author":"Y Xie","year":"2019","unstructured":"Xie Y, Liu LL, Jiang Y, Tang ZZ, Sun GY, Hou XL. Adalimumab for treatment of very early onset inflammatory bowel disease. Chin Med J (Engl). 2019;132(23):2889\u201390.","journal-title":"Chin Med J (Engl)"},{"issue":"5","key":"4592_CR15","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1097\/MPG.0000000000003730","volume":"76","author":"U Cucinotta","year":"2023","unstructured":"Cucinotta U, Arrigo S, Dipasquale V, Gramaglia SMC, Lagana F, Romano C, et al. Clinical course of very Early-Onset inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2023;76(5):590\u20135.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"3","key":"4592_CR16","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s10875-014-9992-8","volume":"34","author":"D Murugan","year":"2014","unstructured":"Murugan D, Albert MH, Langemeier J, Bohne J, Puchalka J, J\u00e4rvinen PM, et al. Very early onset inflammatory bowel disease associated with aberrant trafficking of IL-10R1 and cure by T cell replete haploidentical bone marrow transplantation. J Clin Immunol. 2014;34(3):331\u20139.","journal-title":"J Clin Immunol"},{"issue":"11","key":"4592_CR17","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1016\/j.crohns.2014.04.004","volume":"8","author":"CH Lee","year":"2014","unstructured":"Lee CH, Hsu P, Nanan B, Nanan R, Wong M, Gaskin KJ, et al. Novel de Novo mutations of the interleukin-10 receptor gene lead to infantile onset inflammatory bowel disease. J Crohn\u2019s Colitis. 2014;8(11):1551\u20136.","journal-title":"J Crohn\u2019s Colitis"},{"issue":"11","key":"4592_CR18","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1093\/ecco-jcc\/jjw102","volume":"10","author":"SH Oh","year":"2016","unstructured":"Oh SH, Baek J, Liany H, Foo JN, Kim KM, Yang SC, et al. A synonymous variant in IL10RA affects RNA splicing in paediatric patients with refractory inflammatory bowel disease. J Crohns Colitis. 2016;10(11):1366\u201371.","journal-title":"J Crohns Colitis"},{"issue":"3","key":"4592_CR19","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1097\/MPG.0000000000000621","volume":"60","author":"OF Beser","year":"2015","unstructured":"Beser OF, Conde CD, Serwas NK, Cokugras FC, Kutlu T, Boztug K, et al. Clinical features of Interleukin 10 receptor gene mutations in children with very early-onset inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2015;60(3):332\u20138.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"4","key":"4592_CR20","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1097\/MIB.0000000000001058","volume":"23","author":"Z Huang","year":"2017","unstructured":"Huang Z, Peng K, Li X, Zhao R, You J, Cheng X, et al. Mutations in Interleukin-10 receptor and clinical phenotypes in patients with very early onset inflammatory bowel disease: A Chinese VEO-IBD collaboration group survey. Inflamm Bowel Dis. 2017;23(4):578\u201390.","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"4592_CR21","first-page":"202","volume":"8","author":"J Kierku\u015b","year":"2013","unstructured":"Kierku\u015b J, Szczepa\u0144ski M, Gliwicz D, D\u0105dalski M, Kotlarz D, Klein C, et al. Interleukin-10 receptor deficiency in a Polish paediatric patient with early onset inflammatory bowel disease. Gastroenterol Review\/Przegl\u0105d Gastroenterologiczny. 2013;8(3):202\u20135.","journal-title":"Gastroenterol Review\/Przegl\u0105d Gastroenterologiczny"},{"issue":"9","key":"4592_CR22","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.3748\/wjg.v24.i9.1035","volume":"24","author":"YH Fang","year":"2018","unstructured":"Fang YH, Luo YY, Yu JD, Lou JG, Chen J. Phenotypic and genotypic characterization of inflammatory bowel disease in children under six years of age in China. World J Gastroenterol. 2018;24(9):1035\u201345.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"4592_CR23","doi-asserted-by":"publisher","first-page":"E13","DOI":"10.1097\/MPG.0000000000002297","volume":"69","author":"A Lekbua","year":"2019","unstructured":"Lekbua A, Ouahed J, O\u2019Connell AE, Kahn SA, Goldsmith JD, Imamura T, et al. Risk-factors associated with poor outcomes in VEO-IBD secondary to XIAP deficiency: A case report and literature review. J Pediatr Gastroenterol Nutr. 2019;69(1):E13\u20138.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"12","key":"4592_CR24","doi-asserted-by":"publisher","first-page":"2958","DOI":"10.1097\/MIB.0000000000000650","volume":"21","author":"WM Sunseri","year":"2015","unstructured":"Sunseri WM, Kugathasan S, Keljo DJ, Greer JB, Ranganathan S, Cross RK, et al. IBD LIVE case Series\u2013Case 3: very Early-Onset inflammatory bowel disease: when genetic testing proves beneficial. Inflamm Bowel Dis. 2015;21(12):2958\u201368.","journal-title":"Inflamm Bowel Dis"},{"key":"4592_CR25","doi-asserted-by":"crossref","unstructured":"Bsharat RK,AbuBshara ME, Karajeh IH, Bast AF, Aljabari TM, Qumsieh OQ, Abumohsen HM, Mereb IM,Aljabari TM. Very early onset of fistulizing inflammatory bowel disease with RIPK1 mutation: a case report. Cureus. 2024;16(3).","DOI":"10.7759\/cureus.55708"},{"key":"4592_CR26","doi-asserted-by":"crossref","unstructured":"Walsh RB, McNaughton P, Nademi Z, Laberko A, Balashov D, Al-Mousa H, Arkwright PD, Wynn RF, Flood T, Williams E, Cant A. Outcomes of hematopoietic stem cell transplantation in 5 patients with autosomal recessive RIPK1-deficiency. J Clin Immunol. 2025;45(1):65.","DOI":"10.1007\/s10875-024-01850-2"},{"issue":"9","key":"4592_CR27","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1093\/ecco-jcc\/jjac045","volume":"16","author":"LV Collen","year":"2022","unstructured":"Collen LV, Kim DY, Field M, Okoroafor I, Saccocia G, Whitcomb SD, et al. Clinical phenotypes and outcomes in Monogenic versus Non-monogenic very early onset inflammatory bowel disease. J Crohn\u2019s Colitis. 2022;16(9):1380\u201396.","journal-title":"J Crohn\u2019s Colitis"},{"issue":"1","key":"4592_CR28","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1002\/jpen.2254","volume":"46","author":"NC Ruiz","year":"2022","unstructured":"Ruiz NC, Kamel AY, Liu X, Pham A, Forsmark C, Glover S. Failure to thrive: A severe manifestation of <\u2009i\u2009>\u2009interleukin 10 receptor A\u2009mutation in adult inflammatory bowel disease. J Parenter Enter Nutr. 2022;46(1):238\u201342.","journal-title":"J Parenter Enter Nutr"},{"key":"4592_CR29","doi-asserted-by":"crossref","unstructured":"Kyodo R, Takeuchi I, Narumi S, Shimizu H, Hata K, Yoshioka T et al. Novel biallelic mutations in the DUOX2 gene underlying very early-onset inflammatory bowel disease: A case report. Clin Immunol. 2022;238.","DOI":"10.1016\/j.clim.2022.109015"},{"issue":"1","key":"4592_CR30","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1097\/PG9.0000000000000139","volume":"3","author":"A Opr\u00e9a","year":"2022","unstructured":"Opr\u00e9a A, Collardeau-Frachon S, Heissat S, Peretti N, Lachaux A, Duclaux-Loras R. Therapeutic approach of very Early-Onset inflammatory bowel disease in a Loeys-Dietz syndrome child. JPGN Rep. 2022;3(1):e139.","journal-title":"JPGN Rep"},{"issue":"4","key":"4592_CR31","doi-asserted-by":"publisher","first-page":"E132","DOI":"10.1097\/MPG.0000000000002854","volume":"71","author":"KP Acker","year":"2020","unstructured":"Acker KP, Borlack R, Iuga A, Remotti HE, Soderquist CR, Okada S, et al. Ruxolitinib response in an infant with Very-early-onset inflammatory bowel disease and Gain-of-function STAT1 mutation. J Pediatr Gastroenterol Nutr. 2020;71(4):E132\u20133.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"4592_CR32","doi-asserted-by":"publisher","first-page":"E1051","DOI":"10.1097\/MEG.0000000000002185","volume":"33","author":"G Angelino","year":"2021","unstructured":"Angelino G, Cifaldi C, Zangari P, Di Cesare S, Di Matteo G, Chiriaco M, et al. Gastric cancer, inflammatory bowel disease and polyautoimmunity in a 17-year-old boy: CTLA-4 deficiency successfully treated with abatacept. Eur J Gastroenterol Hepatol. 2021;33:E1051\u20136.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"2","key":"4592_CR33","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/pde.15432","volume":"41","author":"N Esfandiari","year":"2024","unstructured":"Esfandiari N, Vandyke S, Porter HJ, Shea K, Morley K, Greene L. A case of mevalonate kinase deficiency, neonatal sweet syndrome, and inflammatory bowel disease. Pediatr Dermatol. 2024;41(2):298\u2013301.","journal-title":"Pediatr Dermatol"},{"issue":"3","key":"4592_CR34","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.jaci.2012.09.025","volume":"131","author":"KR Engelhardt","year":"2013","unstructured":"Engelhardt KR, Shah N, Faizura-Yeop I, Kocacik Uygun DF, Frede N, Muise AM, et al. Clinical outcome in IL-10- and IL-10 receptor-deficient patients with or without hematopoietic stem cell transplantation. J Allergy Clin Immunol. 2013;131(3):825\u201330.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"4592_CR35","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.gtc.2018.07.004","volume":"47","author":"E Crowley","year":"2018","unstructured":"Crowley E, Muise A. Inflammatory bowel disease what very early onset disease teaches Us. Gastroenterol Clin N Am. 2018;47(4):755\u201372.","journal-title":"Gastroenterol Clin N Am"},{"issue":"6","key":"4592_CR36","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1053\/j.gastro.2016.08.055","volume":"151","author":"DS Shouval","year":"2016","unstructured":"Shouval DS, Biswas A, Kang YH, Griffith AE, Konnikova L, Mascanfroni ID, et al. Interleukin 1\u03b2 mediates intestinal inflammation in mice and patients with Interleukin 10 receptor deficiency. Gastroenterology. 2016;151(6):1100\u20134.","journal-title":"Gastroenterology"},{"issue":"12","key":"4592_CR37","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1086\/657308","volume":"51","author":"G Uzel","year":"2010","unstructured":"Uzel G, Orange JS, Poliak N, Marciano BE, Heller T, Holland SM. Complications of tumor necrosis factor-\u03b1 Blockade in chronic granulomatous disease-related colitis. Clin Infect Dis. 2010;51(12):1429\u201334.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"4592_CR38","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1016\/j.jaip.2017.07.035","volume":"5","author":"N Campbell","year":"2017","unstructured":"Campbell N, Chapdelaine H. Treatment of chronic granulomatous disease\u2013associated fistulising colitis with Vedolizumab. J Allergy Clin Immunology: Pract. 2017;5(6):1748\u20139.","journal-title":"J Allergy Clin Immunology: Pract"},{"issue":"9","key":"4592_CR39","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1080\/00365521.2021.1946588","volume":"56","author":"M Attauabi","year":"2021","unstructured":"Attauabi M, H\u00f6glund C, Fassov J, Pedersen KB, Hansen HB, Wildt S, et al. Vedolizumab as first-line biological therapy in elderly patients and those with contraindications for anti-TNF therapy: a real-world, nationwide cohort of patients with inflammatory bowel diseases. Scand J Gastroenterol. 2021;56(9):1040\u20138.","journal-title":"Scand J Gastroenterol"},{"issue":"9","key":"4592_CR40","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1016\/j.dld.2021.11.014","volume":"54","author":"M Attauabi","year":"2022","unstructured":"Attauabi M, Madsen GR, Bendtsen F, Seidelin JB, Burisch J. Vedolizumab as the first line of biologic therapy for ulcerative colitis and crohn\u2019s disease - a systematic review with meta-analysis. Dig Liver Dis. 2022;54(9):1168\u201378.","journal-title":"Dig Liver Dis"},{"key":"4592_CR41","doi-asserted-by":"publisher","first-page":"660520","DOI":"10.3389\/fped.2021.660520","volume":"9","author":"AC Mudde","year":"2021","unstructured":"Mudde AC, Booth C, Marsh RA. Evolution of our Understanding of XIAP deficiency. Front Pead. 2021;9:660520.","journal-title":"Front Pead"},{"key":"4592_CR42","doi-asserted-by":"crossref","unstructured":"Hoffmann D, Sens J, Brennig S, Brand D, Philipp F, Vollmer Barbosa P, Kuehle J, Steinemann D, Lenz D, Buchegger T, Morgan M. Genetic correction of IL-10RB deficiency reconstitutes anti inflammatory regulation in iPSC-derived macrophages. J Pers Med. 2021;11(3):221.","DOI":"10.3390\/jpm11030221"},{"issue":"227","key":"4592_CR43","doi-asserted-by":"publisher","first-page":"ra22733","DOI":"10.1126\/scitranslmed.3007280","volume":"6","author":"CJ Braun","year":"2014","unstructured":"Braun CJ, Boztug K, Paruzynski A, Witzel M, Schwarzer A, Rothe M, et al. Gene therapy for Wiskott-Aldrich Syndrome\u2014Long-Term efficacy and genotoxicity. Sci Transl Med. 2014;6(227):ra22733\u201333.","journal-title":"Sci Transl Med"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-04592-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04592-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04592-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T01:06:48Z","timestamp":1770772008000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-025-04592-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4592"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-04592-6","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]},"assertion":[{"value":"4 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Mohamed Attauabi has received a research grant from Novo Nordisk Fonden and speaker\u2019s fees from Eli Lilly outside this research. For the remaining authors, none is declared.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"113"}}